GlassScriptPhysician profile
Jeromy David Dyer
NPI 1003927633
$698.44
in general payments reported to CMS, 2019-2025
15 companies · $214 in 2025
The $214 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $270 · 2022: $145 · 2023: $68.45 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $282.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $142.37 | 2021 | |
| Bioventus LLC | $124.50 | 2021-2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Sanofi-Aventis U.S. LLC | $58.14 | 2022-2023 | |
| Vertex Pharmaceuticals Incorporated | $56.92 | 2025 | |
| Horizon Therapeutics Plc | $48.99 | 2021 | |
| Depuy Synthes Sales INC. | $48.32 | 2021-2025 | Monovisc |
| Endo Pharmaceuticals INC. | $40.15 | 2022-2023 | Xiaflex |
| Kci USA, INC. | $30.74 | 2022-2023 | V.A.C. Veraflo, Prevena |
| Pacira Pharmaceuticals Incorporated | $30.48 | 2022-2023 | Iovera |
| Amgen INC. | $27.00 | 2025 | Krystexxa |
| Endo USA, INC. | $23.96 | 2025 | Xiaflex |
| Trevena, INC. | $19.21 | 2021 | |
| Medtronic, INC. | $16.45 | 2022 | |
| Heron Therapeutics, INC. | $15.85 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $15.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeromy Dyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.